Sun, Sep 21, 2014, 1:56 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Chelsea Therapeutics Internatio Message Board

  • mekadik007 mekadik007 May 7, 2013 1:51 PM Flag



    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • bad advice!!!! chtp is a lock for approval end of 2013. the next northera trial, post approval, will certainly have falls as secondary end point. lets not forget about ch-1504- once northera is approved, they will bring that back into the game; license it out to big pharma, run another trial, take a partner or sell the rights entirely. for all the newbies, chtp also has the i-3d portfolio. it is preclinical but has huge potential and promise! i still think they might get scooped up by a bigger company soon after northera is approved. pps will be about 5-6$ at that point which would put market cap around 400 million... what would be a fair price at that point- something where everyone is happy. 8-10 $ per share smells about right( assuming northera is approved q4 this year. orphan status makes the drug MUCH more appealing to a suitor!!!! I like an even billion for the company- about 13$ per share- would likely need euro approval as well to demand that kind of money. any real longterm longs deserve a nice payday, we have endured some hell of a rollercoaster ride the last year or two. was hard not to sell when the stock hit .70$= so i did what buffet would do......Bought MORE. .........also a good chance they take a partner to market northera in the usa( already very clear they will partner for euroupe marketing) GLTA

      Sentiment: Buy

    • ARNA is garbage, can't sell their fat pills 1.7 billion market cap and almost no sales. Why buy a bloated pig?

    • been in and finally sea lets loose. easy double if not triple coming. should have been sitting in high teens if ws didnt bet againdst it

6.520.00(0.00%)Jun 23 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.